Search results
Results from the WOW.Com Content Network
Investors can now consider renewable products company Amyris (NASDAQ:AMRS) as a "marijuana stock." The Emeryville, California-based firm signed a deal to license cannabinoid products. This sent ...
Shares of bioscience firm Amyris (AMRS) skyrocketed more than 70% on Tuesday after the company announced a collaboration deal focused on developing, licensing, and commercializing cannabinoid ...
Amyris, Inc. (AMRS) closed at $3.96 in the latest trading session, marking a +1.02% move from the prior day.
Amyris was founded in 2003. [4] The company owns three brands, Biossance and Pipette, for beauty and skincare, and Purecane, a sugar substitute.The company went public on NASDAQ on September 28, 2010 (AMRS).
Business Insider's Oracles of Wall Street list highlights the top forecasters among economists, strategists, and analysts each year.
MTs255-12 (МЦ255-12) – police version (for ammunition 12/70 and 12/76), designed for law enforcement and security agencies, is distinguished by accessories made of black plastic, folding stock and a "Picatinny rail" bar for attaching sighting devices.
Amyris (AMRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amyris, Inc. (AMRS) closed the most recent trading day at $4.48, moving +0.45% from the previous trading session.